In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Eltrombopag is an oral thrombopoietin receptor agonist that provides an effectiv···【more】
Release date:2026-02-13Recommended:195
The immunotherapy drug Promacta (eltrombopag) has recently been granted an expan···【more】
Release date:2026-02-13Recommended:134
Severe Aplastic Anemia (SAA) is a relatively serious and rare blood disorder. If···【more】
Release date:2026-02-13Recommended:128
Selpercatinib is a National Comprehensive Cancer Network (NCCN) recommended trea···【more】
Release date:2026-02-12Recommended:149
If you experience side effects, your doctor may adjust your dose, temporarily st···【more】
Release date:2026-02-12Recommended:117
Osimertinib is used to treat lung cancer. It works by blocking a protein that he···【more】
Release date:2026-02-11Recommended:145
Tell your healthcare provider about all the medicines you take, including prescr···【more】
Release date:2026-02-11Recommended:97
Medicines are sometimes used for purposes other than those listed in the patient···【more】
Release date:2026-02-11Recommended:124
Osimertinib is used for the prevention of recurrence in patients with non-small ···【more】
Release date:2026-02-11Recommended:98
Selumetinib is an oral small‑molecule kinase inhibitor.How to Take SelumetinibSw···【more】
Release date:2026-02-10Recommended:144
Before taking selumetinib, tell your doctor about all your medical conditions, i···【more】
Release date:2026-02-10Recommended:150
Selumetinib is used to treat type 1 neurofibromatosis (NF1) in pediatric patient···【more】
Release date:2026-02-10Recommended:114